A Randomised Multi-centre Study to Compare the Short-term Outcomes of Minimally Invasive and Conventional Surgery in Primary Total Hip Replacement

May 9, 2016 updated by: DePuy International

Randomised, Prospective, Post-Market Surveillance Study Comparing the Outcomes of Minimally Invasive and Conventional Surgical Procedures in Subjects Requiring Primary Total Hip Arthroplasty for Osteoarthritis.

The purpose of this study is to compare the short-term outcomes of two surgical techniques, minimally invasive and conventional, when used in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to undergo surgery using the minimally invasive or conventional surgical technique and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments with a focus on short term rehabilitation.

Study Overview

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Warwick, United Kingdom
        • Warwick Hospital NHS Trust
    • South Yorkshire
      • Rotherham, South Yorkshire, United Kingdom
        • Rotherham General Hospitals NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 73 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

i) Male or female subjects, aged between 18 and 75 years inclusive.

ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.

iii) Subjects who in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.

iv) Subjects with a primary diagnosis of osteoarthritis.

v) Subjects considered suitable for a primary total hip arthroplasty and are considered suitable for a minimally invasive surgical procedure.

Exclusion Criteria:

i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study, or extend their time to discharge beyond that required for their hip replacement surgery.

ii) Women who are pregnant.

iii) Subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes.

iv) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s).

v) Subjects who are currently involved in any injury litigation claims.

vi) Subjects with a Body Mass Index (BMI) > 30.

vii) Subjects with a malunion, arthrodesis or severe dysplasia with superior femoral head migration.

viii) Subjects requiring a simultaneous bilateral total hip arthroplasty.

ix) Subjects undergoing the second stage of a staged bilateral who are less than 9 months post-arthroplasty

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 1
DePuy MI System
A minimally invasive surgical technique used in total hip replacement.
Active Comparator: 2
Conventional surgical technique
A conventional surgical technique used in total hip replacement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of hours post-operatively after which subjects are first able to mobilise with a frame or crutches
Time Frame: First post-operative day
First post-operative day
Level of assistance required to perform 3 functional tasks (supine to sit, sit to stand and bed to chair transfer)on the second post-operative day
Time Frame: Second post-operative day
Second post-operative day
Time taken (in seconds) for subjects to walk 10 metres on the second post-operative day.
Time Frame: Second post-operative day
Second post-operative day
Amount of time (in seconds) for which subjects are able to stand on the operative leg on the second post-operative day.
Time Frame: Second post-operative day
Second post-operative day

Secondary Outcome Measures

Outcome Measure
Time Frame
Haematological parameters assessed over a 56 hours post op
Time Frame: 56 hours post-operatively
56 hours post-operatively
Pain levels and wound condition
Time Frame: Until discharge
Until discharge
Trendelenberg sign
Time Frame: Until discharge and at 6 weeks
Until discharge and at 6 weeks
Day of discharge
Time Frame: Until discharge
Until discharge
Activity levels over specified distances
Time Frame: Until discharge
Until discharge
Harris Hip score
Time Frame: 6 weeks, 6 months, 1 yr, 2 yrs, 5 yrs and 10 yrs post-surgery
6 weeks, 6 months, 1 yr, 2 yrs, 5 yrs and 10 yrs post-surgery
Oxford Hip score
Time Frame: 6 weeks, 6 months, 1 yr, 2 yrs, 5 yrs and 10 yrs post-surgery
6 weeks, 6 months, 1 yr, 2 yrs, 5 yrs and 10 yrs post-surgery
Radiological analysis
Time Frame: 6weeks, 6mths, 1yr, 2yrs, 5yrs and 10yrs post-surgery
6weeks, 6mths, 1yr, 2yrs, 5yrs and 10yrs post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2005

Primary Completion (Actual)

December 1, 2007

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

September 13, 2005

First Submitted That Met QC Criteria

September 13, 2005

First Posted (Estimate)

September 21, 2005

Study Record Updates

Last Update Posted (Estimate)

May 11, 2016

Last Update Submitted That Met QC Criteria

May 9, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • CT02/29

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis(Primary)

Clinical Trials on DePuy MI System

3
Subscribe